VDEPT: An enzyme/prodrug gene therapy approach for the treatment of metastatic colorectal cancer

Advanced Drug Delivery Reviews

Volumn 17, Issue 3, 1995, Pages 279-292

  Huber, Brian E ^a   Richards, Cynthia A ^a   Austin, Elizabeth A ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; DRUG THERAPY; ENZYMES; ONCOLOGY; TISSUE; VIRUSES;

CANCER; CHIMERIC GENE; COLORECTAL CARCINOMA; GENE THERAPY; HUMAN CARCINOEMBRYONIC ANTIGEN GENE; HUMAN TUMOR XENOGRAFTS; LIVER TUMORS; RETROVIRAL VECTORS; SURGICAL RESECTION; TRANSCRIPTIONAL REGULATORY SEQUENCE;

GENETIC ENGINEERING;

5 ETHYNYLURACIL; CARCINOEMBRYONIC ANTIGEN; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GANCICLOVIR; PRODRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER GRAFT; CHIMERA; COLORECTAL CARCINOMA; CONFERENCE PAPER; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; LIVER METASTASIS; METASTASIS; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RETROVIRUS; SOLID TUMOR; SURVIVAL RATE;

EID: 0029637158     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(95)00062-C     Document Type: Review

References (18)

1. Current approaches to metastatic colorectal cancer
2. Recent advances in the treatment of advanced colorectal cancer
3. Treatment of advanced colorectal cancer
4. Advanced colorectal cancer: Impact of chemotherapy on survival
5. The role of chemotherapy in the treatment and prohylaxis of colorectal liver metastases
6. Current issues in the treatment of colorectal cancer
7. A first step in the development of gene therapy tor colorectal carcinoma: cloning, sequencing and expression of Escherichia coli cytosine deaminase
8. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase
9. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase
10. Virus-directed enzyme/prodrug therapy (VDEPT) selectively engineering drug sensitivity into tumors
11. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy
12. Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy
13. Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil
14. Locaization of CEA messenger RNA by in situ hybridization in normal colonic mucosa and colorectal adenocarcinomas
15. Transcription of carcinoembryonic antigen in normal colon and colon carcinoma
16. Definition of expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas
17. Tumor concentration and distribution of carcinoembryonic antigen measured by in vitro quantitative autoradiography